Marlex Pharmaceuticals, an acquisition target of ScripsAmerica, has shipped and invoiced the first order of an 8 year pharmaceutical distribution contract with the United States Department of Defense and Defense Logistics Agency (DLA).
Last week the company initially announced the 8-year government distribution contract with the Office of Health Affairs (OHA), a branch of the US.
Department of Homeland Security has agreed to buy a minimum of $25m pharmaceuticals within the first three years.
ScripsAmerica CEO Bob Schneiderman said the shipment and invoicing of Marlex's first pharmaceutical order to the Department of Defense marks the official start of a multi-year contract.
''We are very excited by this development and look forward to Marlex and subsequently ScripsAmerica successfully receiving and shipping additional orders for years to come," Schneiderman added.
